Principal Financial Group’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.08M Sell
63,933
-6,349
-9% -$208K ﹤0.01% 1819
2025
Q4
$2.23M Buy
70,282
+25,077
+55% +$754K ﹤0.01% 1822
2025
Q3
$1.06M Buy
+45,205
New +$775K ﹤0.01% 1916
2024
Q2
Sell
-10,451
Closed -$141K 2457
2024
Q1
$141K Sell
10,451
-1,586
-13% -$9.61K ﹤0.01% 2233
2023
Q4
$63.3K Sell
12,037
-94
-0.8% -$402 ﹤0.01% 2314
2023
Q3
$47.8K Buy
12,131
+743
+7% +$4.89K ﹤0.01% 2349
2023
Q2
$121K Buy
+11,388
New +$121K ﹤0.01% 2262
2021
Q3
Sell
-8,365
Closed -$282K 2620
2021
Q2
$282K Buy
+8,365
New +$296K ﹤0.01% 2381
2020
Q4
Sell
-6,658
Closed -$223K 2458
2020
Q3
$223K Buy
+6,658
New +$190K ﹤0.01% 2183

Other funds holding STOK